Register
Medicines reference
Active substance

Miltefosine

Alkylphosphocholine antiprotozoal. Registered in Georgia: 1 veterinary product. Forms: solution.

Dose and use

Doses

Each dose comes with its source. Check the label of the product you use.

Active substance Miltefosine
Before use

Safety information

Known Contraindications

  • Critical
    Do not use in dogs hypersensitive to miltefosine or excipients.
    Sources: EU SPC
  • Critical
    Do not use during pregnancy: teratogenic, foetotoxic and embryotoxic in laboratory animals.
    Sources: EU SPC
  • Critical
    Do not use during lactation.
    Sources: EU SPC
  • Warning
    Do not use in breeding animals. Must not be given by pregnant women or women who may be pregnant; wear impervious gloves.
    Sources: EU SPC
  • Caution
    Severe liver impairment: use only after a benefit-risk assessment.
    Sources: EU SPC
  • Caution
    Severe heart impairment: use only after a benefit-risk assessment.
    Sources: EU SPC
Latin name
Miltefosine
Georgian name
მილტეფოზინი
Authorisation status
Authorised veterinary medicine
An authorised veterinary medicine containing this substance exists. Whether a particular use is on-label depends on the species and the indication - see each dose rule.
Registered in Georgia
1 of 1 forms
Products
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 18 Oct 2026
All forms and registration1

Registration in Georgia and abroad: the register, number, validity and source are behind (i).

Milteforan 20 mg/ml, Solution

miltefosine 20 mg/ml, oral solution for dogs
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog
7.8/10
Good
vetman assessment

Milteforan

20 mg/ml, miltefosine 20 mg/ml, oral solution for dogs
Assessed clinical scopeDog · Labelled treatment of clinical canine leishmaniosis as part of an appropriate combination protocol · By mouth
Care settingVeterinary-directed outpatient treatment with staging, combination therapy and long-term relapse monitoring
vetman score 7.8/10 Good
Evidence confidence: High Georgia: Yes, veterinary · № 26-11 · Verified on 21 Oct 2026

A strong, evidence-supported component of combination treatment for clinical canine leishmaniosis; never use it as stand-alone curative therapy.

Regulatory and scientific credibility8.5/10

The exact 20 mg/ml oral solution has current EU product information and active Georgian veterinary registration (26-11), supported by a current specialist consensus.

Clinical efficacy8.0/10

Miltefosine 2 mg/kg daily for 28 days with allopurinol is a guideline-supported first-line combination with consistent clinical improvement, but it is not curative and monotherapy is not recommended.

Safety and tolerability7.0/10

Vomiting, diarrhoea and reduced appetite are recognised; pregnancy, lactation and breeding are contraindicated, and severe hepatic or cardiac disease requires benefit-risk assessment.

Clinical practicality7.5/10

Once-daily food-based liquid dosing is workable, but accurate weight dosing, gloves and completion of a 28-day course materially affect clinical delivery.

Full-course cost-effectiveness-

Price was not assessed and is excluded from the overall score.

Important safety and use flags

  • Do not use during pregnancy, lactation or in breeding animals; pregnant or potentially pregnant women must not administer it.
  • Use with allopurinol in an appropriate staged protocol; monotherapy is not recommended and parasitological cure is not expected.
Assessment sources
Assessed: 21 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Miltefosine20 mg/ml
Formulation Type
Solution
Administration route
By mouth
Manufacturer
Virbac · France
Manufacturer (register)
VIRBAC, France
Manufacturer and country as in the veterinary medicines register (National Food Agency), row 1652, 19 Oct 2026.
Registration
Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: მილტეფორანი® (მილტეფოსინა 2%)
№ 26-11
Verified on: 21 Oct 2026
EU Yes, veterinary
№ NL/V/0405/001
Verified on: 18 Oct 2026
UK No
Verified on: 18 Oct 2026
US No
Verified on: 18 Oct 2026
Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 18 Oct 2026

All of this shows in vetman as you prescribe

The dose for the patient's weight, registration in Georgia and controlled status, right on the prescription.